Search

July 28, 2023

Nyxoah to Release Second Quarter 2023 Financial Results on August 8, 2023

Mont-Saint-Guibert, Belgium – July 27, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA),

Nyxoah to Participate in the 43rd Canaccord Genuity Growth Conference

Nyxoah to Participate in the 43rd Canaccord Genuity Growth Conference Mont-Saint-Guibert, Belgium – July 27, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and